SAN DIEGO, Sept. 29, 2016 /PRNewswire/ -- Medipacs, Inc., a San Diego-based commercialization-stage medical device company, announced the appointment of industry veteran Michael J. Kamdar to the newly created position of Executive Chairman of the Board. Mr. Kamdar joins with more than 25 years of domestic and international pharmaceutical and biotechnology leadership experience as founder, Board member and Senior Executive of notable pharmaceutical and biotechnology companies such as Agouron Pharmaceuticals, Warner-Lambert, Pfizer, Anadys Pharmaceuticals, VentiRx Pharmaceuticals, Tobira Therapeutics and Ciclofilin Pharmaceuticals. In these roles, Mr. Kamdar has successfully raised hundreds of millions of dollars to fund development and commercialization of pharmaceutical products and completed numerous strategic and corporate transactions totaling more than $1 billion.
"We are very pleased to have someone of Mike's caliber on the Medipacs team," said Mark McWilliams, CEO of Medipacs. "Mike has represented some of the most successful pharmaceutical and biotechnology companies in the community. His leadership, commercialization and financing experience will be invaluable to Medipacs as we seek to form strategic relationships with pharmaceutical companies to develop and commercialize simple, convenient patient-use infusion devices for their biologic drugs."
"I'm very excited to join the Board of Medipacs at such a pivotal time for the company," said Mr. Kamdar, "Medipacs' technology is best in class and has the potential to revolutionize the way in which patients are treated with biologic drugs. The benefits to patients could be remarkable, and I look forward to working with the Board to realize this potential."
With the election of Mr. Kamdar, Medipacs Board of Directors now includes: Mark McWilliams, CEO, a serial medical device entrepreneur; Harry George, co-founder of Solstice Capital; Jim Utts, a 30-year veteran of infusion products sales and distribution at Baxter; Mark Banister, technology inventor and founder.
Medipacs, Inc. is a San Diego-based commercialization-stage medical device company with expertise in hydrogel polymers and subcutaneous drug administration devices. The company is developing advanced infusion products based on its proprietary, expanding polymer and is now focused on its first commercial pump, a programmable, wearable, disposable infusion device. For information, please contact Mark McWilliams, CEO, at: (858) 204-6411 or visit www.medipacs.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medipacs-appoints-michael-j-kamdar-as-executive-chairman-300336229.html
SOURCE Medipacs, Inc.